Cargando…
Efficacy of recombinant human interleukin-11 in preventing and treating oral mucositis after chemotherapy for patients with acute leukemia
OBJECTIVE: This study aimed to investigate the clinical effects of recombinant human interleukin-11 (rhIL-11) gargle on preventing and treating oral mucositis (OM) after chemotherapy for acute leukemia. METHODS: This single-site, prospective, observer-blinded, nonrandomized controlled trial was cond...
Autores principales: | Zhang, Yilin, Li, Yuxin, He, Aili, Wang, Jin, Zhang, Pengyu, Lei, Bo, Huang, Zhuan, Zhang, Lin, Zhao, Wei, Ma, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337102/ https://www.ncbi.nlm.nih.gov/pubmed/37438702 http://dx.doi.org/10.1186/s12903-023-03118-4 |
Ejemplares similares
-
A prospective interventional study of recombinant human interleukin-11 mouthwash in chemotherapy-induced oral mucositis
por: Wei, Hangping, et al.
Publicado: (2022) -
Efficacy Oral Glutamine to Prevent Oral Mucositis and Reduce Hospital Costs During Chemotherapy in Children with Acute Lymphoblastic Leukemia
por: Widjaja, Nur Aisiyah, et al.
Publicado: (2020) -
Prevention and treatment of oral mucositis
in patients receiving chemotherapy
por: Alvariño-Martín, Carlos, et al.
Publicado: (2014) -
Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
por: Daugėlaitė, Goda, et al.
Publicado: (2019) -
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
por: Liu, Na-wei, et al.
Publicado: (2019)